Journal article
Antithrombotic Therapy During Percutaneous Coronary Intervention The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Abstract
This chapter about antithrombotic therapy during percutaneous coronary intervention (PCI) is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs. Grade 2 suggests that individual patients' values may lead to different choices (for a full understanding of the grading, see Guyatt …
Authors
Popma JJ; Berger P; Ohman EM; Harrington RA; Grines C; Weitz JI
Journal
CHEST Journal, Vol. 126, No. 3, pp. 576s–599s
Publisher
Elsevier
Publication Date
September 2004
DOI
10.1378/chest.126.3_suppl.576s
ISSN
0012-3692
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AbciximabAngioplasty, Balloon, CoronaryAntibodies, MonoclonalAspirinClopidogrelContraindicationsCoronary RestenosisCoronary StenosisDrug Therapy, CombinationEvidence-Based MedicineFibrinolytic AgentsHeparinHirudinsHumansImmunoglobulin Fab FragmentsPeptide FragmentsPractice Guidelines as TopicPyridinesRecombinant ProteinsRisk AssessmentStentsTiclopidine